SMOKING AND VAPING RESEARCH STUDIES
Altasciences has significant experience in cannabis, nicotine, and tobacco smoking research studies, both in the U.S. and Canada. We are invited members of the CORESTA (Cooperation Center for Scientific Research Relative to Tobacco) subcommittee on Smoking Behavior and Biomarkers, where we actively contribute to white papers concerning the latest requirements for clinical pharmacology studies needed for regulatory submission.
Smoking Research Studies
Our clinics are specially designed for smoking clinical trials, with dedicated air handling systems, as well as robust databases of participants who smoke and/or vape. Our clients depend on us to deliver the robust nicotine and tobacco research they need.
Since 2016, we have conducted more than 10 smoking research studies on electronic nicotine delivery systems (ENDS) or heat-not-burn products, with endpoints ranging from abuse potential, nicotine pharmacokinetics, and biomarkers of exposure and harm, to topography.
Our bioanalytical lab has been analyzing nicotine in blood and total urinary nicotine equivalents for years, and has developed a robust SOP for nicotine decontamination that ensures staff or participants do not contaminate the tubes. We have validated biomarkers of exposure, such as for tobacco-specific nitrosamines (TSNAs).
As experts in smoking research studies, we also conduct research in smoking cessation.
- 60,000+ smokers in our database
- 10+ studies on vaping products since 2016
Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide comprehensive support research services and bioanalytical expertise.